About TB-REP

In September 2015 a US$ 6 million grant agreement was signed between the Global Fund and the Centre for Health Policies and Studies (PAS Centre; as the principal recipient of a regional grant to boost tuberculosis (TB) control. The grant agreement, supported by the WHO Regional Office for Europe and partners, covers 11 countries from eastern Europe and central Asia: Armenia, Azerbaijan, Belarus, Georgia, Kazakhstan, Kyrgyzstan, Republic of Moldova, Tajikistan, Turkmenistan, Ukraine and Uzbekistan.

Duration: January 2016 to December 2018

Goal and key objectives
The overall goal of this project is to decrease the burden of TB disease and halt the spread of drug resistance in the 11 EECA countries by increasing political commitment and translating evidence into the implementation of patient centered TB models of care. The project aims to translate existing good practices at the country level and replicate them, in a feasible, rational, cost-effective and context-adapted manner, across eastern Europe and central Asia.

There are two main objectives:
1. To increase political commitment to end TB through regional cooperation and evidence sharing for effective and sustainable transformation of health systems;
2. To support countries to implement effective and efficient TB service delivery systems with sustainable financing.

The TB-REP will translate the lessons learned at country and regional levels over the past 20 years into practice and build on the momentum to act with urgency to reverse the spread of TB epidemics, strengthen systems and address inequities. The EECA region countries demonstrated the commitment of the TB control efforts to contribute to stronger health systems and thereby greater health impact. In this context, the TB-REP will offer a broad set of concrete actions on how Prime Minister offices, Ministries of Health, Social Protection, Justice/Interior and Finance can contribute together to this challenging agenda.  TB-REP will develop and promote a concise set of activities at the regional level in order to facilitate implementation of patient-centered care in each and every country.

The EECA TB control activities are directly linked to the priorities of the Consolidated Action Plan to Prevent and Combat Multidrug and Extensively Drug-Resistant Tuberculosis in the WHO European Region 2011–2015 and to the regional Tuberculosis action plan for the WHO European Region 2016–2020, the latter of which is in line with the global End TB Strategy.